Ozempic manufacturer Novo Nordisk's sponsored content to be probed by TGA
Novo Nordisk comments on role of off-label use in Ozempic shortfall
Novo Nordisk officially opens new Sydney headquarters - BioPharmaDispatch
Novo Nordisk engages Thermo Fisher to produce weight-loss drug
Ozempic, Weight-Loss Drugs Are Being Investigated For Suicide Risks - Bloomberg
Novo Nordisk wins first smart insulin pen approval for diabetes in China | BioWorld
Novo Nordisk Pharmaceuticals Pty. Limited - Great Place To Work Australia
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company - YouTube
Quality Control Issues at Novo Nordisk's Clayton Plant - Key Site for Weight-Loss, Diabetes Drug Production
Novo Nordisk to launch two connected insulin pens, taps Flex to manage data | MobiHealthNews
Novo Nordisk - National Association of Diabetes Centres
Drugmaker behind Ozempic, Wegovy begins legal proceedings against certain med spas, clinics and compounding pharmacies | CNN
Novo Nordisk Pharmaceuticals Pty. Limited - Great Place To Work Australia
Novo Nordisk Foundation invests $136m in new cell therapy facility - Pharmaceutical Technology
Signal: Novo partners with Valo Health for up to $2.7bn
NovoPen 6 - new reusable insulin pen – Bionic Wookiee
Betting on Obesity chapter one: politics, money and a company called Novo Nordisk
Pharmaceutical News - Australia's untapped potential in clinical trials sector
Best Places to Work Certification Program on LinkedIn: #australia #newzealand #certification #pharma #culture #leadership…
Novo's Wegovy Approved After Superior Weight-Loss Impact Shown - Bloomberg
Novo Nordisk lifts 2022 outlook after strong quarter, shares jump | Reuters
New leadership for Novo Nordisk | MedNews
Novo Nordisk Pharmaceuticals Pty. Limited - Great Place To Work Australia
Contact Novo Nordisk - our local offices
